Poplar Therapeutics

Poplar is developing next-generation anti-IgE antibodies for atopic diseases, including food allergy, asthma, and atopic dermatitis.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2026